Financials Krka, d. d.

Equities

KRKG

SI0031102120

Pharmaceuticals

End-of-day quote Ljubljana S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
125.5 EUR +0.40% Intraday chart for Krka, d. d. -0.40% +14.09%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,320 2,862 3,676 2,857 3,402 3,869 - -
Enterprise Value (EV) 1 2,101 2,558 3,373 2,338 3,228 3,355 3,326 3,089
P/E ratio 9.47 x 9.86 x 11.9 x 7.87 x 10.8 x 11.6 x 11.1 x 10.6 x
Yield 4.37% 5.47% 4.24% 6.12% 6% 5.56% 5.83% 5.99%
Capitalization / Revenue 1.55 x 1.86 x 2.35 x 1.66 x 1.88 x 2.06 x 1.98 x 1.87 x
EV / Revenue 1.41 x 1.67 x 2.15 x 1.36 x 1.79 x 1.79 x 1.7 x 1.49 x
EV / EBITDA 5.45 x 5.09 x 7.27 x 4.78 x 6.4 x 6.47 x 6.13 x 5.63 x
EV / FCF 9.35 x 10.2 x 10.5 x 6.27 x 36.7 x 12.2 x 11.3 x 9.81 x
FCF Yield 10.7% 9.82% 9.49% 16% 2.73% 8.22% 8.83% 10.2%
Price to Book 1.44 x 1.64 x 2.02 x 1.41 x 1.65 x 1.8 x 1.69 x -
Nbr of stocks (in thousands) 31,690 31,313 31,152 31,052 30,925 30,832 - -
Reference price 2 73.20 91.40 118.0 92.00 110.0 125.5 125.5 125.5
Announcement Date 3/19/20 3/18/21 3/17/22 4/13/23 3/14/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,493 1,535 1,566 1,717 1,806 1,874 1,956 2,068
EBITDA 1 385.4 502.4 463.6 488.9 504.2 518.6 542.2 549.1
EBIT 1 274.2 390.7 354.8 381.2 399.6 406.9 420.5 435.6
Operating Margin 18.36% 25.46% 22.66% 22.2% 22.12% 21.71% 21.5% 21.06%
Earnings before Tax (EBT) 1 284.4 339 362.4 433.1 367.1 409 425.5 422.5
Net income 1 245.5 291 309.2 363.3 313.9 343.4 358.6 369.1
Net margin 16.44% 18.96% 19.75% 21.15% 17.38% 18.32% 18.34% 17.84%
EPS 2 7.730 9.270 9.920 11.69 10.14 10.81 11.31 11.82
Free Cash Flow 1 224.7 251.2 320.2 372.9 88.04 275.8 293.5 314.9
FCF margin 15.05% 16.36% 20.45% 21.71% 4.87% 14.71% 15.01% 15.22%
FCF Conversion (EBITDA) 58.3% 49.99% 69.06% 76.28% 17.46% 53.18% 54.14% 57.35%
FCF Conversion (Net income) 91.52% 86.31% 103.55% 102.65% 28.04% 80.31% 81.85% 85.32%
Dividend per Share 2 3.200 5.000 5.000 5.630 6.600 6.982 7.320 7.520
Announcement Date 3/19/20 3/18/21 3/17/22 4/13/23 3/14/24 - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 219 304 303 519 174 515 543 781
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 225 251 320 373 88 276 294 315
ROE (net income / shareholders' equity) 15.2% 17.1% 17% 17.9% 14.5% 15.1% 14.9% 14.5%
ROA (Net income/ Total Assets) - - 13% 13.9% 11.5% 11.7% 11.8% 11.3%
Assets 1 - - 2,387 2,614 2,730 2,935 3,039 3,266
Book Value Per Share 2 50.90 55.80 58.50 65.20 66.50 69.80 74.20 -
Cash Flow per Share - - - - - - - -
Capex 1 111 80.8 72.1 94.7 139 144 144 143
Capex / Sales 7.41% 5.27% 4.61% 5.52% 7.71% 7.69% 7.35% 6.92%
Announcement Date 3/19/20 3/18/21 3/17/22 4/13/23 3/14/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
125.5 EUR
Average target price
133.6 EUR
Spread / Average Target
+6.49%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. KRKG Stock
  4. Financials Krka, d. d.